New patent for Exeltis Usa drug DROSPIRENONE
Annual Drug Patent Expirations for DROSPIRENONE Drospirenone is a drug marketed by Exeltis Usa Inc, Barr, Glenmark Pharms Ltd, Hetero Labs, Hlthcare, Jubilant Cadista, Mylan Labs Ltd, Watson Labs, Apotex,…![](https://www.drugpatentwatch.com/blog/wp-content/plugins/matomo/app/matomo.php?idsite=1&rec=1&url=https%3A%2F%2Fwww.drugpatentwatch.com%2Fblog%2Fnew-patent-for-exeltis-usa-drug-drospirenone-5%2F&action_name=New%20patent%20for%20Exeltis%20Usa%20drug%20DROSPIRENONE&urlref=https%3A%2F%2Fwww.drugpatentwatch.com%2Fblog%2Ffeed%2F)